Download PDF
CC BY-NC-ND 4.0 · The Arab Journal of Interventional Radiology 2020; 4(02): 130-133
DOI: 10.4103/AJIR.AJIR_33_19
Case Report

Partial Splenic Artery Embolization for Idiopathic Warm Autoimmune Hemolytic Anemia Refractory to Medical Therapy

Mohamad Omar Hadied
Department of Radiology, Henry Ford Health System, Detroit, MI, USA
,
Riyad Yazan Kherallah
Department of Internal Medicine, Baylor College of Medicine Medical Center, Houston, TX, USA
,
Mariam Salman
University of Michigan Medical School, Ann Arbor, MI, USA
,
Khalid Eteer
School of Medicine, Wayne State University, Detroit, MI, USA
,
Scott Schwartz
Department of Radiology, Henry Ford Health System, Detroit, MI, USA
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Purpose: While Partial Splenic Artery Embolization (PSAE) is a useful procedure that has been performed for a variety of indications including trauma and hypersplenism, it has only been rarely described as a treatment for Idiopathic Warm Autoimmune Hemolytic Anemia. Previous reports in the literature are limited to case reports in situations that include the patient being a poor surgical candidate, the inability to transfuse blood during surgery because of autoantibodies, and a patient's refusal of blood products on religious grounds. Materials and Methods: A case report describing the case of a 27-year-old male diagnosed with idiopathic warm Autoimmune Hemolytic Anemia treated successfully with partial splenic artery embolization (PSAE) as a bridging therapy to definitive surgical splenectomy. Results: The patient's pre-procedure hemoglobin was 2.1 g/dl. The first hemoglobin post-procedure was 4.5 g/dl. After embolization, the patient remained in the inpatient setting for eight days for close observation. During the inpatient hospitalization the patient's hemoglobin continued to trend upwards until it stabilized around 6 g/dl. Inpatient laboratory workup also showed increasing haptoglobin, and decreasing LDH. After discharge, the patient developed persistent pain two months post-procedure. An elective splenectomy was scheduled three months after the embolization procedure to address the persistent pain. Six months' post embolization procedure and three months postoperatively, the patient is doing well clinically with a hemoglobin of 14 g/dl. Conclusion: In conclusion, this case demonstrates the utility of a Partial Splenic Artery Embolization (PSAE) as an acute life-saving intervention for poor surgical candidates with idiopathic warm Autoimmune Hemolytic Anemia (AIHA) refractory to medical therapy.

Keywords:

Splenic artery embolization - autoimmune hemolytic anemica - embolization - anemia


Publication History

Received: 25 November 2020
Received: 31 December 2020

Accepted: 22 January 2020

Article published online:
26 March 2021

© 2020. The Arab Journal of Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. https://creativecommons.org/licenses/by-nc-nd/4.0/.

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Spigos DG, Jonasson O, Mozes M, Capek V. Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol 1979;132:777-82.
  • 2 Madoff DC, Denys A, Wallace MJ, Murthy R, Gupta S, Pillsbury EP, et al. Splenic arterial interventions: Anatomy, indications, technical considerations, and potential complications. Radiographics 2005;25 Suppl 1:S191-211.
  • 3 Miyazaki M, Itoh H, Kaiho T, Ohtawa S, Ambiru S, Hayashi S, et al. Partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura. AJR Am J Roentgenol 1994;163:123-6.
  • 4 Guan YS, Hu Y. Clinical application of partial splenic embolization. ScientificWorldJournal 2014;2014:961345.
  • 5 Creelan B, Thomas K, Massis K, Davis RM. Splenic arterial embolization for idiopathic warm auto-immune haemolytic anaemia. Br J Haematol 2013;161:2.
  • 6 Durusu Tanrıöver M, Peynircioǧlu B, Ergan Arsava B, Topeli İskit A. Splenic artery embolization: An alternative approach in a critically ill patient with autoimmune hemolytic anemia. Turk J Haematol 2011;28:135-8.
  • 7 Berentsen S. How I manage cold agglutinin disease. Br J Haematol 2011;153:309-17.
  • 8 Molica M, Massaro F, Annechini G, Baldacci E, D'Elia GM, Rosati R, et al. Life-threatening autoimmune hemolytic anemia and idhiopatic thrombocytopenic purpura. Successful selective splenic artery embolization. Mediterr J Hematol Infect Dis 2016;8:e2016020.
  • 9 Crowther M, Chan YL, Garbett IK, Lim W, Vickers MA, Crowther MA. Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults. Blood 2011;118:4036-40.
  • 10 Akpek G, McAneny D, Weintraub L. Comparative response to splenectomy in Coombs-positive autoimmune hemolytic anemia with or without associated disease. Am J Hematol 1999;61:98-102.